ArticleClinical pharmacokinetics2026

Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration.

Q Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.